Frequently debrided and misdiagnosed: Post-surgical pyoderma gangrenosum

Main Article Content

Lindsey Wold Fraser
Stephanie A Castillo
Shabnam Momtahen
Michael Shane Chapman


pyoderma gangrenosum, post-operative, surgical complications


Post-surgical pyoderma gangrenosum is rare. On average it develops 10 days after a surgical procedure. This timeframe is similar to post-operative wound infections, including post-operative necrotizing fasciitis. Consequently, post-surgical pyoderma gangrenosum is frequently misdiagnosed as an infection, leading to detrimental surgical debridement, unnecessary antibiotic use, and delay of proper treatment. We review a case of pyoderma gangrenosum of the right inguinal crease following percutaneous coronary catheterization and review of the literature.


1. Almukhtar R, Armenta A, Martin J, et al. Delayed diagnosis of post-surgical pyoderma gangrenosum: A multicenter case series and review of the literature. International Journal of Surgery Case Reports. 44 (2018), 152-156.

2. S.N. Tolkachjov, et al.Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014. J. Am. Acad. Dermatol., 73 (4) (2015), pp. 615-622

3. Tolkachjov SN et al. Postoperative Pyoderma Gangrenosum: A Clinical Review of Published Cases. Mayo Clin Proc. 2016 Sep; 91(9): 1267-79.

4. Ogata K et al. Pyoderma gangrenosum in an abdominal surgical site: a case report. Surg Case Rep. 2015 Dec; 1:122.

5. Wang C et al. Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis, and therapeutic strategies. Crit Rev Oncol Hematol. 2018 Feb; 122. 123-132.

6. Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol. 2003 Feb; 30(2): 97-107.

7. Le Cleach L et al. Is topical monotherapy effective for localized pyoderma gangrenosum? Arch Dermatol. 2011; 147: 101-3.

8. Thomas et al. Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study. J Am Acad Dermatol. 2016 Nov; 75(5): 940-949.

9. Leiphart PA et al. Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon depridement. JAAD Case Rep 2017 Dec 20; 4(1): 98-100.